Oncology Assay Articles & Analysis
6 news found
INOVOTION’s high-value preclinical oncology assay quickly identifies your most effective anticancer drug candidates. ...
Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and custom assay development on dedicated clinical instruments. Bio-Techne's genomic tools include advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand as ...
Today, Thermo Fisher Scientific announces a new portfolio of hematology-oncology assays for the Ion Torrent Genexus System* designed to enable a future in which turnaround times for next-generation sequencing (NGS) results can be reduced to less than 24 hours. The Oncomine Myeloid Assay GX* is the first in a series of clinical research ...
For some, it has deeply impacted their ability to serve customers in circumstances where time is of the essence," said Garret Hampton, president of clinical next-generation sequencing and oncology at Thermo Fisher Scientific. "At this unprecedented time, sustaining the momentum in oncology is paramount. ...
Thermo Fisher Scientific today announced that it has expanded its strategic partnership with Agios Pharmaceuticals by adding the co-development of a second companion diagnostic (CDx) for oncology to their existing agreement. The CDx will leverage the Oncomine Precision Assay, which runs on the new Ion Torrent Genexus System, and will be used globally to identify ...
Delivering on that need will mean that hematology and oncology labs can quickly get the results they need." Expanded Portfolio Addresses Full Range of Hematology Applications Thermo Fisher also announced an expanded portfolio of NGS-based hematology-oncology research assays that make it easier to assess lymphoid malignancies. ...